ImmunoGen, Inc.: capex
| Value | {"amount": 1782000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2011-07-01 – 2012-03-31 |
| Status | current |
| Entity | ImmunoGen, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:28:05.952928+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7bb4fae0-ce69-4cc1-b87f-fd0b76410557
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-12-035820 · Open the official SEC filing →Retrieved: 2026-08-19T08:28:05.952928+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000855654/capex/2012-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7bb4fae0-ce69-4cc1-b87f-fd0b76410557
History
- no predecessors — first report